Calendar

No events are planned

Říhová Blanka

Prof., RNDr., DrSc.
Born October 21, 1942 in Prague

  • Immunology
  • Member of Learned Society since 1996

Educational and professional preparation:

  • 1959, graduate, Eighth eleven-year secondary school, Prague;
  • 1964, graduate biology, Faculty of Science, Charles University (FS CU);
  • 1966, RNDr., FS CU; 1969, CSc., Institute of Microbiology (IM), CSAS;
  • 1993, Associate Professor in immunology, CU;
  • 1993, DrSc., IM, CSAS; 2
  • 2001, Full Professor in immunology, CU.

Employment and academic positions:

  • 1963-1964, Research Assistant, FS CU;
  • 1964-1966, IM, CSAS; Department of Immunology, study stay;
  • 1966-1969, IM, CSAS; Department of Immunology, internal PhD student;
  • 1969-1974, IM, CSAS; Department of Immunology, Postdoctoral Research Associate;
  • 1974-1989, IM, CSAS; Principal Research Officer;
  • 1987-1988, Oklahoma Medical Research Foundation; Senior Academic Visitor;
  • 1989-1990, IM, CSAS; Department of Immunology, Leading Research Scientist;
  • 1990-2000 Division of Immunology and Gnotobiology, Deputy Head;
  • 1990-present, Head, Laboratory of Humoral Immunity, IM, AS CR;
  • 1992-2000, Associate Professor of pharmacy and pharmaceutical chemistry, University of Utah, Salt Lake City (USA);
  • 2003 visiting professor, University Paris-Nord, France (1 month);
  • 2000-present, Director, IM, AS CR;
  • 2000-present, Professor of pharmacy and pharmaceutical chemistry, University of Utah, Salt Lake City

Membership in domestic scientific bodies (selection):

  • 1990-present, Member, Academy Assembly
  • 1992-1992, Member, Scientific Council, IM, AS CR
  • 1992-2000, Chairperson, Scientific Council, IM, AS CR
  • 1994-2000, Member, Council for Sciences, AS CR
  • 1996-2000, Member, Presidium, Grant Agency of Czech Republic
  • 2000-2002, Member, Scientific Council, Institute of Chemical Technology (ICT)
  • 2000-present, Member, Scientific Council FS CU
  • 2001-present, Member, Scientific Council, Second Faculty of Medicine CU
  • 2002-present, Member, Professional Commission for the Science of Living Nature, Council for Research and Development
  • 2003-present, Member, Special Commission 08 - Infectious Diseases, Microbiology, Epidemiology and Immunology, Scientific Council, Internal Grant Agency of Ministry of Health of Czech Republic
  • 2003-present, Member, Commission of the Council for Sciences, AS CR for Defence of Doctoral Theses in “Microbiology, Virology and Mycology”
  • 2003-present, Member, Commission of the Scientific Council of AS CR for Defence of Doctoral Theses in „Immunology“
  • 2003-present, Member, Scientific Council of AS CR for Defence of Doctoral Theses in „Biochemistry, Biophysics and Molecular Biology“
  • 2003-present, Member, Special Subcommission 301, Grant Agency of Czech Republic (GA CR) in Molecular Biology, Genetics and Oncology

Membership and positions in international organizations and societies:

  • 1963-present, Member, Czechoslovak Microbiological Society
  • 1971-1979, Member, Biological Society, CSAS
  • 1979-present, Czechoslovak (Czech) Immunological Society,
  • 1989-1992, 1994-1997, 2000-present - member of the committee
  • 1981-present, Member, J. E. Purkyně Medical Society
  • 1982-present, Member, UPAC commission “Interaction of Polymers with Living Systems”
  • 1982-present, Member, Chemical Society of CSAS (AS CR)
  • 1985-present, Member of the International Society for Molecular Recognition
  • 1993-present, Director, Society for Leukocyte Biology (Eastern European branch with registered address in Prague)
  • 1993-present, Member, Society for Leukocyte Biology, International Relations Committee
  • 1994-2000, Member, Sigma Xi
  • 1995-present, Member, Controlled Release Society
  • 1998-present, Member, European Science Foundation (ESF) Standing Committee for Life and Environmental Science (LESC)
  • 1998-2002, member, All European Academies (ALLEA) Steering Committee
  • 2000-present, Member, ESF/EURESCO Committee
  • 2001-present, Member of the American Association for Cancer Research
  • 2001-present, Member, American Diabetes Association
  • 2002-present, Elected Member, European Academy of Sciences

Notable awards:

  • 1972, Award, CSAS
  • 1982, Award, CSAS
  • 1983, Award, CSAS
  • 1987, J. E. Purkyně Medal (for results obtained in biology) (CSAS)
  • 2000, Medal, Faculty of Medicine, Chiang Mai University, Thailand
  • 2002, Award, Czech Society of Allergology and Clinical Immunology (for contributions to the development of the field of allergology and clinical immunology)
  • 2004, Prof. Dr. Wolf A. Kafka Verdienstmedaille

Selected publications:

  • B. Říhová, J. Kopeček: Biological properties of targetable poly N-(2-hydroxypropyl)- methacrylamide - antibody conjugates. J. Control. Rel. 2, 289 (1985)
  • B. Říhová, P. Kopečková, J. Strohalm, P. Rossmann, V. Větvička, J. Kopeček: Antibody directed affinity therapy applied to the immune system: In vivo effectiveness and limited toxicity of daunomycin conjugated to HPMA copolymers and targeting antibody. Clin. Immunol. Immunopathol. 46, 100 (1988)
  • B. Říhová, K. Ulbrich, J. Strohalm, V. Větvička, M. Bilej, R. Duncan, J. Kopeček: Biocompatibility of N-(2-hydroxypropyl)methacrylamide copolymers containing adriamycin. Biomaterials 10, 335 (1989)
  • B. Říhová, N.L. Krinick, J. Kopeček: Targetable photoactivatable drugs. J. of Material Science. Materials in Medicine 2, 238 (1991)
  • B. Říhová, A. Jegorov, J. Strohalm, V. Maťha, P. Rossmann, L. Fornůsek, K. Ulbrich: Antibody-targeted cyclosporin A. J. Control. Rel. 19, 25 (1992)
  • B. Říhová, J. Šrogl, M. Jelínková, M. Burešová, V. Šubr, K. Ulbrich: HPMA-based biodegradable hydrogels containing different forms of doxorubicin; antitumor effects and biocompatibility. Ann. NY. Acad. Sci.: Bioartificial Organs, Science, Medicine and Technology 831, 57 (1997)
  • B. Říhová, J. Strohalm, K. Kubáčková, M. Jelínková, O. Hovorka, M. Kovář, D. Plocová, M. Šírová, M. Šťastný, L. Rozprimová, K. Ulbrich: Acquired and specific immunological mechanisms co-responsible for efficacy of polymerbound drugs. J. Control. Rel. 78, 97 (2002)
  • B. Říhová, J. Strohalm, K. Kubáčková, M. Jelínková, L. Rozprimová, M. Šírová, D. Plocová, T. Mrkvan, M. Kovář, J. Pokorná, T. Etrych, K. Ulbrich: Drug-HPMA-HuIg conjugates effective against human solid cancer. Polymer Drugs in the Clinical Stage (Maeda et al., Eds.). Kluwer Academic/Plenum Publishers, New York (2003), 125
  • B. Říhová, J. Strohalm, J. Prausová, K. Kubáčková, M. Jelínková, L. Rozprimová, M. Šírová, D. Plocová, T. Etrych, V. Šubr, T. Mrkvan, M. Kovář, K. Ulbrich: Cytostatic and immunomobilizing activities of polymer-bound drugs: experimental and first clinical data. J. Control. Rel. 91, 1 (2003)
  • B. Říhová, K. Kubáčková: Clinical implications of N-(2-hydroxy-propyl)methacrylamide copolymers. Current Pharmaceutical Biotechnology 4, 311 (2003)

Back to the list of articles

News

25.07.19

Luboš Perek is celebrating his 100th year

Founding fellow of the Learned Society and its doyen, astronomer doc. RNDr. Luboš Perek, DrSc, is celebrating his 100th birthday on 26 July 2019. He is an indelible part of history as the person who helped define cosmic space, he was the first to point out the issue of cosmic waste and was also a teacher to the most important Czechoslovak astronomers. Let us express our respect and admiration of the extraordinary scientific career of a person who worked tirelessly and continues to work. The Learned Society wishes Mr Perek health, optimism and joy in the oncoming years.

23.07.19

The Academy of Sciences of the Czech Republic has appealed to the Hungarian President to support academic freedom

On Friday 19 July the Academy of Sciences of the Czech Republic and the Learned Society of the Czech Republic sent a letter to Hungarian President János Ánder, in which they state their concerns regarding the situation in respect to management and funding of scientific activities in Hungary. An act, according to which not the Academy of Sciences, but a thirteen-member political committee, will decide on research, funding of scientific activities and establishment or closure of scientific workplaces, will come into force on 1 September.

07.07.19

The loss of Learned Society Fellow prof. Josef Koutecký

We regret to inform that prof. Josef Koutecký, a fellow of the Learned Society, a renowned physician and the founder of paediatric oncology in this country, passed away on 5 July 2019 at the age of 88. He founded paediatric oncology here in 1964 and a separate paediatric oncology department was then established at the Faculty Hospital in Motol, Prague in 1978.